BIOLASE Past Earnings Performance

Past criteria checks 0/6

BIOLASE's earnings have been declining at an average annual rate of -7.3%, while the Medical Equipment industry saw earnings growing at 12% annually. Revenues have been growing at an average rate of 11.4% per year.

Key information

-7.3%

Earnings growth rate

71.6%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate11.4%
Return on equityn/a
Net Margin-34.7%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Biolase partners with dental speciality programs across U.S.

Aug 31

BIOLASE: Ongoing Operating Losses, Capital Raises To Sustain Liquidity

Jul 21

BIOLASE amends senior secured term loan with SWK Funding

Jul 01

BIOLASE: Bad News Across The Board - Sell

Mar 21

Is BIOLASE (NASDAQ:BIOL) Weighed On By Its Debt Load?

Feb 24
Is BIOLASE (NASDAQ:BIOL) Weighed On By Its Debt Load?

BIOLASE - Speculative Buy After Strong Preliminary Q4 Results

Jan 11

BIOLASE - Good News Across The Board But Still Only Suited For The Most Speculative Investors

Nov 24

Revenue & Expenses Breakdown

How BIOLASE makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:BIOL.Q Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2446-16245
30 Jun 2446-27265
31 Mar 2449-38276
31 Dec 2349-38286
30 Sep 2350-42326
30 Jun 2351-38347
31 Mar 2349-30347
31 Dec 2248-29347
30 Sep 2247-24337
30 Jun 2244-19306
31 Mar 2241-14286
31 Dec 2139-17276
30 Sep 2135-18256
30 Jun 2132-32245
31 Mar 2126-36225
31 Dec 2023-34214
30 Sep 2024-32214
30 Jun 2027-20234
31 Mar 2032-19254
31 Dec 1938-18255
30 Sep 1941-21275
30 Jun 1943-20275
31 Mar 1946-21295
31 Dec 1846-22305
30 Sep 1846-18285
30 Jun 1846-18276
31 Mar 1846-22276
31 Dec 1747-21266
30 Sep 1748-21277
30 Jun 1750-22287
31 Mar 1752-17287
31 Dec 1652-18278
30 Sep 1652-16267
30 Jun 1650-16267
31 Mar 1648-19287
31 Dec 1548-20297
30 Sep 1547-22267
30 Jun 1548-20276
31 Mar 1547-19275
31 Dec 1447-19315
30 Sep 1449-17314
30 Jun 1449-18304
31 Mar 1453-14284
31 Dec 1356-11284

Quality Earnings: BIOL.Q is currently unprofitable.

Growing Profit Margin: BIOL.Q is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: BIOL.Q is unprofitable, and losses have increased over the past 5 years at a rate of 7.3% per year.

Accelerating Growth: Unable to compare BIOL.Q's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: BIOL.Q is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.4%).


Return on Equity

High ROE: BIOL.Q's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies